Drugs / Copper Gluconate
Copper Gluconate
also known as
Copper (as gluconate) · Copper d-gluconate (1:2) · Copper(ii) gluconate · Cupric gluconate · Cuprum gluconicum
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04521335 | May → Dec 2021 | plasma cell myeloma | University of Utah | Terminated | No outcome recorded |
| Phase 1 | NCT00742911 | Jul 2008 → Mar 2013 | cancer | University of Utah | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02715609 | Jun 2016 → May 2024 | glioblastoma | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03034135 | Mar 2017 → Jul 2018 | glioblastoma | Cantex Pharmaceuticals | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT05210374 Background | Mar 2023 → Sep 2026 expected | sarcoma | Case Comprehensive Cancer Center | Recruiting | No outcome recorded |
| Phase 1 | NCT02963051 Background | Jul 2017 → Dec 2018 | prostate cancer | Daniel George, MD | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03714555 Comparator | Oct 2019 → Jul 2020 | malignant pancreatic neoplasm | HonorHealth Research Institute | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Copper gluconate | “Disulfiram/copper gluconate is taken three times a day.” NCT03034135 ↗ |
| Known as | Copper (as gluconate) | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068389 ↗ |
| Known as | Copper d-gluconate (1:2) | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068389 ↗ |
| Known as | Copper(ii) gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068389 ↗ |
| Known as | Cupric gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068389 ↗ |
| Known as | Cuprum gluconicum | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068389 ↗ |
| Modality | Small molecule | — CHEMBL6068389 ↗ |
| Route | Oral | “Copper gluconate will be administered orally at a dose of 1.5 mg three times a day” NCT02963051 ↗ |